Amyloidogenic and non-amyloidogenic pathways of amyloid precursor protein processing in oligodendrocytes
Brain Research · 2025
DOI: 10.1016/j.brainres.2025.149601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Misaki Hida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Health Sciences, Kyoto University Graduate School of Medicine, Japan. Hauptthemen laut MEDLINE: Oligodendroglia, Amyloid beta-Protein Precursor, Amyloid beta-Peptides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency Moonshot Research and Development Program, Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency.
Abstract (Originalsprache)
Excessive accumulation of toxic amyloid-β (Aβ) species in the brain is a major pathological process triggering neurodegeneration in Alzheimer's disease (AD). Recent studies indicate that both neurons and glial cells, including oligodendrocyte lineages (OLs), contribute to brain homeostasis and affect AD pathology; however, the roles of oligodendrocyte precursor cells (OPCs) and oligodendrocytes (OLGs) in AD remain to be fully elucidated. This study examined Aβ production and related protein expression in primary cultured OLs. Primary cultured OLs produced Aβ40 and Aβ42 and expressed amyloid precursor protein (APP), β-secretase (BACE1) and γ-secretase (PS1) as well as α-secretase (ADAM10). OLGs express APP770 in addition to APP695. Treatment with a γ-secretase inhibitor reduced Aβ40 and Aβ42 production levels derived from OPCs/OLGs and suppressed OPC differentiation. Additionally, conditioned media from OLGs improved neuronal cell viability under oxidative stress and contained higher levels of sAPPα compared to OPCs. The neuroprotective effect of OLG was diminished by a sAPPα inhibitor, suggesting that OLG-derived sAPPα protects neurons under oxidative stress. These findings revealed that OLs produce pathogenic Aβ40/42 via the amyloidogenic pathway and secrete neuroprotective sAPPα via the non-amyloidogenic pathway. Elucidating the pathological shift from beneficial non-amyloidogenic to harmful amyloidogenic processes in OLs during AD onset and progression would provide crucial insights into novel therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Health Sciences, Kyoto University Graduate School of Medicine, Japan.
- Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
- Human Health Sciences, Kyoto University Graduate School of Medicine, Japan; Neurology of Department of Neuroscience Research Center, Shiga University of Medical Science, Japan.
- Department of Neurology, Kyoto University Graduate School of Medicine, Japan. Electronic address: harutoma@kuhp.kyoto-u.ac.jp.
Förderung
- Japan Science and Technology Agency Moonshot Research and Development Program
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Hida, M., Yasuda, K., Toyokawa, M., Asada-Utsugi, M., Toda, S., Yanagida, N., Takahashi, R., Kinoshita, A., & Maki, T. (2025). Amyloidogenic and non-amyloidogenic pathways of amyloid precursor protein processing in oligodendrocytes. Brain Research. https://doi.org/10.1016/j.brainres.2025.149601
Vancouver
Hida M, Yasuda K, Toyokawa M, Asada-Utsugi M, Toda S, Yanagida N, et al. Amyloidogenic and non-amyloidogenic pathways of amyloid precursor protein processing in oligodendrocytes. Brain Research. 2025. doi:10.1016/j.brainres.2025.149601
BibTeX
@article{Hida2025,
author = {Hida, Misaki and Yasuda, Ken and Toyokawa, Masaru and Asada-Utsugi, Megumi and Toda, Shintaro and Yanagida, Narufumi and Takahashi, Ryosuke and Kinoshita, Ayae and Maki, Takakuni},
title = {Amyloidogenic and non-amyloidogenic pathways of amyloid precursor protein processing in oligodendrocytes},
journal = {Brain Research},
year = {2025},
doi = {10.1016/j.brainres.2025.149601}
}
EUVIMED